Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 03, 2015 10:01 AM ET


Company Overview of Agios Pharmaceuticals, Inc.

Key Executives for Agios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David P. Schenkein M.D.39 RelationshipsChief Executive Officer, President and Director57
Lewis Clayton Cantley Ph.D.89 RelationshipsCo-Founder, Director, Member of Scientific Advisory Board and Member of Science & Technology Committee65
Tak Wah Mak Ph.D., D.Sc.,FRSC167 RelationshipsCo-Founder and Member of Scientific Advisory Board68
Shin-San Su Ph.D.No RelationshipsCo-Founder and Senior Vice President of Research & Development58
Craig B. Thompson M.D.137 RelationshipsCo-Founder and Chairman of Scientific Advisory Board61
View More Key Executives

Agios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin P. Starr 88 RelationshipsThird Rock Ventures, LLC51
David P. Schenkein M.D. 39 RelationshipsAgios Pharmaceuticals, Inc.57
Lewis Clayton Cantley Ph.D. 89 RelationshipsAgios Pharmaceuticals, Inc.65
Tak Wah Mak Ph.D., D.Sc.,FRSC 167 RelationshipsAgios Pharmaceuticals, Inc.68
Craig B. Thompson M.D. 137 RelationshipsAgios Pharmaceuticals, Inc.61
View All Board Members

Agios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee M.B.A.Paul J. Clancy26 Relationships4 Executives
Compensation Committee Ph.D.Marc Tessier-Lavigne83 Relationships4 Executives
Nominating Committee Kevin P. Starr88 Relationships2 Executives
Corporate Governance Committee Kevin P. Starr88 Relationships2 Executives
Advisory Board M.D.Craig B. Thompson137 Relationships10 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$425.0K
Total Value of Options
Compensation as of Fiscal Year
Agios Pharmaceuticals, Inc. CEO Compensation
Industry Average


Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at